TABLE 3.
Treatment‐emergent adverse events in FE
| Fasting, N = 16 | Fed, N = 16 | |
|---|---|---|
| TEAE | 8 (50.0) | 8 (50.0) |
| Elevated blood triglycerides | 5 (31.3) | 5 (31.3) |
| Elevated blood bilirubin | 2 (12.5) | 0 |
| Elevated alanine aminotransferase | 1 (6.3) | 1 (6.3) |
| Elevated blood pressure | 1 (6.3) | 0 |
| Positive urine leukocytes | 0 | 1 (6.3) |
| Positive urine erythrocytes | 0 | 1 (6.3) |
| Intraventricular conduction block | 0 | 1 (6.3) |
| Elevated blood creatine phosphokinase | 0 | 1 (6.3) |
| Elevated blood uric acid | 0 | 1 (6.3) |
| Increased total bile acids | 0 | 1 (6.3) |
| Headache | 1 (6.3) | 0 |